Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Mastering B-cell biomarker tracking in autoimmune therapy 11 days 8 hours 34 mins 9 secs SAVE YOUR SEAT!

Infographic: HRMS in DMPK

28 Nov 2019
General interest

As part of our Spotlight on HRMS, we carried out a survey to gain an insight into the trends, challenges and developments associated with the use of HRMS for DMPK studies. We would like to thank everyone who was able to share their thoughts by taking part in the survey – you can see the results below in our infographic.

HRMS in DMPK spotlight infographic_NM-01-min

< Back to – Spotlight: HRMS in DMPK

Top content

  • How blockchain and AI are transforming data integrity in bioanalysis
  • Onsite media partners confirmed for PharmSci 360 2025
  • Novartis to acquire Avidity Biosciences in $12B deal to boost RNA therapeutics pipeline

Related tags

DMPK HRMS infographic QQQ Survey
Previous article Next article

Related articles

3 SEP 2019 GENERAL INTEREST
Infographic: trends in LBA
19 AUG 2019 JOURNAL ARTICLES
Microflow UPLC and high-resolution MS as a sensitive and robust platform for quantitation of intact peptide hormones
13 OCT 2016 INTERVIEWS
Using HRMS in Bioanalysis – A conversation with Rand Jenkins and Patrick Bennett
23 FEB 2016 CLINICAL
Modify on the fly: triple quad to high resolution in support of a dermal clinical study requiring an ultra low LLOQ
23 APR 2025 INTERVIEWS
RadioADME studies of oligonucleotides: an interview with Deborah Watson
2 MAR 2018 MS (LC–MS/MS, HRMS, IMS)
1. What molecules do you predominantly work with, and (how/why) do you use HRMS for their analysis?
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone